Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ITUS Corp (NASDAQ:ITUS)

2.10
Delayed Data
As of 11:58am ET
 +0.05 / +2.44%
Today’s Change
1.85
Today|||52-Week Range
6.82
-61.11%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$19.9M

Company Description

ITUS Corp. engages in the development, acquisition, and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered in Los Angeles, CA.

Contact Information

ITUS Corp.
12100 Wilshire Boulevard
Los Angeles California 90025
P:(310) 484-5200
Investor Relations:
(310) 484-5184

Employees

Shareholders

Individual stakeholders10.13%
Other institutional0.83%
Mutual fund holders0.75%

Top Executives

Robert Andrew BermanPresident, Chief Executive Officer & Director
Dean KrouchSecretary & Operations Director
Michael J. CatelaniCFO & Principal Accounting Officer
John A. RoopSenior Vice President-Engineering
Anthony CampisiVice President-Engineering